Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


Med Ad News Insider

Archive for the ‘ Sales & Marketing ’ Category

Cegedim Dendrite finds industry focused on changing business model

Friday, June 18th, 2010

The top issue vexing pharmaceutical executives is the changing commercial business model, according to "2010 Pharma Insights," a new report from Cegedim Dendrite. The pharma CRM and data solutions company conducted an online survey of 211 pharmaceutical executives in North and South America. Thirty-five percent of surveyed executives cited the ...

Genentech again tops among oncologists, hematologists

Monday, May 17th, 2010

Although Genentech is still seen by oncologists and hematologists as the company with the best overall image, that lead has been challenged by Novartis Oncology, according to a study by the strategic consulting firm Market Strategies International. The company's syndicated study identifies which companies are perceived by oncologists and hematologists to ...

Cost can be high for regulatory noncompliance

Thursday, April 22nd, 2010

Tonight, following the 21st Annual Manny Awards honoring outstanding acheivements in healthcare advertising, our April issue will be unveiled along with all the winners. Meanwhile, our May issue, including one of our regular features on promotional medical education, is in full production. For last year’s promotional medical education feature, I had ...

Reps still welcome in large numbers, but appointments remain popular

Wednesday, March 17th, 2010

Even as pharmaceutical companies scale back their sales forces, physicians are almost unanimous in reporting visits from as many as 20 sales reps each week from the pharmaceutical or medical device industries. Research conducted by SK&A, A Cegedim Company, found 98% of surveyed physicians open their doors to up to ...

All my Rx’s come from Texas

Thursday, February 18th, 2010

SK&A, A Cegedim Company, has recently released a report, “Top 50 U.S. ZIP Codes With Most Physicians,” which as the name implies provides a list of the densest groupings of U.S. physicians geographically. Interestingly, among the top 11 zip codes, four are located in the state of Texas, including the ...

Healthcare ad agencies chime in on recall incentives

Thursday, February 11th, 2010

This month, General Motors took advantage of Toyota's recall misfortune and public relations silence by revealing a shiny new purchase-and-lease incentive program targeting Toyota and Lexus customers. GM's program running through February, allows Toyota owners who end their lease to receive up to $1,000 off a new or leased GM ...

New e-book provides marketing tips for the year ahead

Wednesday, February 3rd, 2010

A contributor to Med Ad News and the founder of AdvanceMarketWoRx, Ellen Hoenig-Carlson has recently released a free e-book titled Best Learning Actions for Healthcare Marketers in 2010. With pharmaceutical companies navigating a complicated environment of new regulations and mediums for communication, the book is designed to help pharmaceutical and ...

Peril and promise of healthcare reform

Monday, December 21st, 2009

Healthcare reform has taken a major step forward as the Democratic caucus voted to curtail debate on the bill. The final vote on the Senate’s version of healthcare reform could come by Christmas, at which point the Senate must then draft a compromise with the House, which approved its own ...

It ain’t easy being green

Tuesday, December 8th, 2009

In these dark days of layoffs and embarrassing legal settlements, it's always nice to see a pharma giant looking out for its sales reps. Or looking out for its sales reps' carbon footprint. That's why I was thrilled Tuesday morning to receive the following press release: ----- Pharm giant sales force goes ...

Well-managed communities key to building brand loyalty

Tuesday, November 17th, 2009

Our November issue has gone online and should be hitting desks right about now. This month features our annual report on generics, and the big story this year is the massive patent cliff facing some of the major pharmaceutical brands. While this should prove to be a boon for the ...